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Experimental infection of male volunteers with Neisseria gonorrhoeae is safe and repro-
duces the clinical features of naturally acquired gonococcal urethritis. Human inoculation
studies have helped deﬁne the natural history of experimental infection with two well-
characterized strains of N. gonorrhoeae, FA1090 and MS11mkC. The human model has
proved useful for testing the importance of putative gonococcal virulence factors for ure-
thral infection in men. Studies with isogenic mutants have improved our understanding
of the requirements for gonococcal LOS structures, pili, opacity proteins, IgA1 protease,
and the ability of infecting organisms to obtain iron from human transferrin and lactoferrin
during uncomplicated urethritis. The model also presents opportunities to examine innate
host immune responses that may be exploited or improved in development and testing of
gonococcal vaccines. Here we review results to date with human experimental gonorrhea.
Keywords: gonorrhea, pathogenesis, infection, urethritis
INTRODUCTION
In nature, gonococcal infection is strictly limited to the human
host. Uncomplicated infection can be asymptomatic or mani-
fest as urethritis in men and cervicitis in women. Complications
resulting from tissue invasion include orchitis, epididymitis and
pelvic inﬂammatory disease, and systemic dissemination can lead
to arthritis, tenosynovitis, or dermatitis. Like other inﬂamma-
tory mucosal infections, gonorrhea also facilitates HIV transmis-
sion and acquisition. Treatment options for gonococcal infection
are dwindling as worldwide, Neisseria gonorrhoeae is becoming
increasing resistant to currently available antibiotics (Lewis, 2010).
Experimental human urethral infection offers the potential to bet-
ter understand the contributions of microbial factors and host
immune responses to infection that may eventually translate into
the development of an effective gonococcal vaccine and provides
an appropriate model for vaccine testing.
The use of live N. gonorrhoeae to cause experimental infection
has a long and sometimes sordid history dating back to the late
eighteenth century when British surgeon John Hunter repeatedly
inoculated patients with“venereal matter” to test whether venereal
disease was infectious (Hunter, 1835). Recent reports of experi-
mental gonorrhea studies conducted during the 1940s in vulner-
able populations who were often deceived and infected without
informed consent highlight the ethical issues that surround clini-
cal research with human subjects (Frieden and Collins, 2010); the
issues are particularly sensitive for experimental human infections
with sexually transmitted pathogens. All of the studies described
herein were subject to rigorous safety and ethical review by appro-
priate Institutional Review Boards. Written informed consent was
obtained from all subjects in accordancewith the ethical principles
set forth in the Declaration of Helsinki and the US Code of Federal
Regulations for the Protection of Human Subjects. Several hun-
dred subjects have participated in experimental infection studies
without reported complications or adverse events.
EXPERIMENTAL MODEL
Experimental gonorrhea is restricted to male subjects; women
cannot safely be included due to potential complications from
ascendant gonococcal infection. Inoculation is accomplished by
the instillation of 0.2–0.3mL of a gonococcal suspension through
a pediatric catheter inserted approximately 5 cm into the ure-
thra. There are slight variations in the preparation and delivery of
experimental inocula used in previously published work detailed
by Cohen and Cannon (1999), Cohen et al. (1994), and Schmidt
et al. (2001). Following inoculation, infection can be monitored
by bacterial recovery from urogenital specimens including urine,
urethral swabs and semen. Gonococcal urethritis is deﬁned by
the development of urethral discharge containing gram negative
diplococci or recovery of gonococci from a urethral swab culture.
Host responses can be monitored by enumeration of white blood
cells in urine and urethral exudates and measurement of soluble
immune mediators including antibodies and cytokines in urine
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and serum. Clinical disease is monitored by daily physical exam-
ination. Subjects receive prompt effective antibiotic treatment as
soon as infection is clinically apparent, when requested because of
intolerance for symptoms or at the end of the experimental trial,
up to 7 days after inoculation, regardless of whether or not the
subject was judged to be infected during the trial.
Two gonococcal strains, N. gonorrhoeae FA1090 and
MS11mkC, have been used in the majority of experimental infec-
tion studies conducted over the past 20 years. FA1090 is a porin
serotype PIB-3 strain originally isolated in the 1970s from the
endocervix of a woman with probable disseminated gonococcal
infection (Nachamkin et al., 1981) and has been used extensively
in experimental infection studies conducted at the University of
North Carolina at Chapel Hill (Cohen et al., 1994; Jerse et al., 1994;
Seifert et al., 1994; Cornelissen et al., 1998; Cohen and Cannon,
1999; Johannsen et al., 1999).MS11 is a porin serotype PIB-9 strain
originally isolated in 1970 fromapatientwith uncomplicated ante-
rior urethritis (Edwards et al.,1984; Swanson et al.,1985).MS11mk
is descended from MS11, and MS11mkC is a lipooligosaccharide
(LOS) variant isolated from an experimentally infected male vol-
unteer in the late 1980s (Schneider et al., 1991). MS11mkC was
used in subsequent volunteer studies conducted at theWalter Reed
Army Institute of Research (Ramsey et al., 1995; Schneider et al.,
1995, 1996; Schmidt et al., 2000, 2001).
N. GONORRHOEAE MS11mkC IS MORE INFECTIOUS THAN
FA1090 IN THE MALE URETHRA
Too few subjects can be included in individual experimental trials
to reliably evaluate the infectivity of a given inoculum. However,
the cumulative experience to date includes sufﬁcient numbers of
subjects and a wide enough range of doses to estimate the rel-
ative infectivities of the two strains. We analyzed available data
from 55 men inoculated with wild-type MS11mkC at doses from
2.5× 102 to 5.7× 104 colony-forming units (cfu; Schneider et al.,
1995; Schmidt et al., 2001 and unpublished data from J. G. Can-
non) and 43 men inoculated with wild-type FA1090 at doses from
1.0× 104 to 3.5× 106 cfu (Cohen et al., 1994 and unpublished
data from J. G. Cannon and M. M. Hobbs). We conducted mul-
tiple logistic regression analyses using SigmaStat version 3.5 for
Windows (Systat Software, Inc., Point Richmond, CA, USA) to
predict the probability of infection over a range of doses for each
strain (Figure 1). The quality of the ﬁt for each dose response
curve was tested using the Hosmer–Lemeshow statistic (Hosmer
and Lemeshow, 2000). A non-signiﬁcant P value (>0.05) indi-
cates a good ﬁt between the logistic equation and the raw data;
P = 0.369 for MS11mkC, and P = 0.878 for FA1090. The esti-
mated dose resulting in infection of 50% of inoculated subjects
(ID50) is 1.8× 103 cfu forMS11mkCand1.0× 105 cfu for FA1090.
Similar differences in infectivity for the two strains have been
observed in the murine model of female genital tract infection
(Jerse, 1999).
The reasons for the apparent nearly 2 log10 difference in ID50
betweenFA1090 andMS11mkC forurethral infection arenot clear.
Great care has been taken to describe and control (as much as pos-
sible) the expression of recognized phase-variable determinants in
experimental inocula. Inoculum variants of both strains used in
the experimental infections included in the dose response analyses
FIGURE 1 | Neisseria gonorrhoeae strain MS11mkC is more infectious
than strain FA1090 in experimental infection of the male urethra.
Multiple logistic regression analysis was used to generate dose response
models with data from 55 men inoculated with MS11mkC (dashed line) and
43 men inoculated with FA1090 (solid line). All inocula contained
predominantly piliated, Opa-negative, wild-type gonococci. The estimated
ID50 (indicated by the horizontal dotted line) is 1.8× 103 cfu for MS11mkC
and 1.0× 105 cfu for FA1090.
contained predominantly piliated (P+), Opacity protein-negative
(Opa−) gonococci expressing the lacto-N -neotetraose LOS epi-
tope recognized by monoclonal antibody (Mab) 3F11, which is
associated with the development of urethral discharge in nat-
urally acquired and experimental gonococcal infection in men
(Schneider et al., 1991). Strains FA1090 andMS11have been exten-
sively characterized in numerous laboratories, and there are many
recognized differences. Though not an exhaustive list, Table 1
summarizes some of the features that differ between FA1090 and
MS11mkC, potentially inﬂuencing infectivity in the experimental
model of urethral infection.
The relatively recent human passage of MS11mkC compared
to FA1090 may also have resulted in unrecognized differences
between the two strains. Though inocula prepared from both
strains have been described as piliated, it is possible thatMS11mkC
is hyperpiliated compared to FA1090.
NATURAL HISTORY OF EXPERIMENTAL INFECTION WITH
WILD-TYPE GONOCOCCI
Despite the apparent difference in infectivity, the course of experi-
mental infection and development of clinical signs and symptoms
caused by wild-type piliated, Opa-negative inocula of N. gon-
orrhoeae strains FA1090, and MS11mkC are very similar. The
clinical and microbiological courses of infection in individual
infected subjects have been described previously (Schneider et al.,
1991, 1995, 1996; Cohen et al., 1994; Jerse et al., 1994; Cohen
and Cannon, 1999; Schmidt et al., 2001) and are summarized
here. Gonococci are recovered at low levels in urine from most
subjects 2 h after inoculation. A so-called eclipse period of vari-
able length ensues during which few or no viable gonococci
are recovered from urine. Then, infected individuals begin to
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Table 1 | Recognized differences between N. gonorrhoeae strains FA1090 and MS11mkC.
Characteristic FA1090 MS11mkC References
Serum susceptibility Resistant Sensitive (characterized as
Intermediate by some)
Cohen et al. (1994),
Ram et al. (2001)
Gonococcal genetic island Absent Present Dillard and Seifert, (2001)
Lactoferrin utilization (expression of
lactoferrin-binding proteins B and A)
Lf− (LbpB-A−) Lf+ (LbpB-A+) Anderson et al. (2003)
Mtr efﬂux pump expression Not inducible due to 11bp deletion
in the coding region of activator
mtrA; wt mtrCDE promoter
Inducible with wt mtrA;
higher expression of pump
due to novel mtrCDE
promoter and missense
mutation in repressor mtrR
Rouquette et al. (1999), Warner
et al. (2008), and W. M. Shafer
(unpublished data)
Lf, lactoferrin; Lbp, lactoferrin-binding protein; Mtr, multiple transferable resistance; bp, base pair; wt, wild-type.
shed increasing numbers of organisms in the urine, though the
number of gonococci recovered from infected subjects does not
correlate with the severity of infection. Bacteriuria persists until
signs and symptoms of infection including dysuria and urethri-
tis develop. Most men experimentally infected with wild-type
gonococci develop gonococcal disease characterized by a urethral
discharge and dysuria, consistent with the clinical presentation
of naturally acquired gonorrhea. The incubation period between
inoculation and development of signs or symptoms of infection is
variable, ranging from 1 to 6 days for both FA1090 and MS11mkC
and is independent of the number of gonococci in the inoculum.
Though rare, asymptomatic experimental infectionwithwild-type
FA1090 variants occurs and is characterized by recovery of gono-
cocci from urine in the absence of signs or symptoms during the
5- to 6-day trial period (J. G. Cannon and A. E. Jerse, unpub-
lished data); asymptomatic infection with MS11mkC has not
been reported.
Cellular and soluble mediators of the host response to exper-
imental infection follow a similar pattern. Pyuria, as determined
by the presence of white blood cells in urine sediment (Cohen
et al., 1994; Ramsey et al., 1995), and elevated urinary interleukin
(IL)-6 and IL-8 (Ramsey et al., 1995) are frequently observed
within the ﬁrst 24 h after inoculation. Whether the early appear-
ance of these inﬂammatory mediators is the result of mild irri-
tation caused by the insertion of the catheter during inoculation
or a direct response to gonococci is not clear. In subjects who
remain uninfected, pyuria resolves (Cohen et al., 1994; Ramsey
et al., 1995), and cytokines quickly return to pre-challenge lev-
els (Ramsey et al., 1995). Pyuria persists in infected subjects, and
the numbers of white blood cells in urine generally increase until
men develop symptoms and require treatment (Cohen et al., 1994;
Ramsey et al., 1995). Elevated levels of inﬂammatory cytokines
IL-6, IL-8, TNFα and IL-1β are consistently detected in urine in
response to experimental infection with MS11mkC or MS11mkA,
(an LOS variant lacking the 3F11 epitope; Schneider et al., 1991;
Ramsey et al., 1995); similar cytokine studies have not been con-
ducted with strain FA1090. The cytokine responses detected in
urine during experimental gonorrhea are comparable to those
seen during bacterial urinary tract infections (Sheu et al., 2006,
2007). During experimental gonococcal urethritis, inﬂammatory
host response indicators generally peak at the onset of symptoms
and return to pre-inoculation levels within 2 days after treat-
ment (Ramsey et al., 1995). Elevated inﬂammatory cytokines in
peripheral circulation are also detected during experimental infec-
tion, returning to baseline after treatment. Cytokines in urine are
uniformly detectable in infected subjects with elevated plasma
cytokines. However, elevated urinary cytokine levels in the absence
of concomitant increases in plasma in some infected subjects sug-
gest local involvement in inﬂammatory responses to experimental
urethral infection (Ramsey et al., 1995).
Because experimentally infected subjects are treated at the
onset of signs or symptoms of infection, assessment of immune
responses is limited to those that occur during the early stages of
infection such as the innate immune responses described above.
Acquired immune responses including production of speciﬁc anti-
bodies are generally thought to require longer exposure than
occurs during experimental infection. However, Schneider and
colleagues demonstrated increases in serum IgG antibodies recog-
nizing gonococcal LOS in 8 of 14 subjects (57%) experimentally
infected for 3–7 days with an ID90 of MS11mkC (Schmidt et al.,
2001). Interestingly, increased anti-LOS antibody titers were sig-
niﬁcantly associated with resistance to homologous reinfection,
though equivalent proportions of previously infected and naïve
subjects were infected with an ID50 challenge (Schmidt et al.,
2001). Men who experienced a fourfold or greater increase in anti-
LOS IgG titer during initial infection were more likely to resist
reinfection than men with lower and static LOS antibody titers
during initial infection. The mechanisms by which anti-LOS anti-
bodies in serum could protect from urethral gonococcal infection
are not clear. Increases in these circulating antibodies may be a
surrogate for protective mucosal immune responses, or transuda-
tion to the urethral mucosa could result from early inﬂammation
in experimental infection. Apicella and colleagues have shown
that gonococcal entry into primary human urethral epithelial
cells is dependent on LOS interactions with the asialoglycopro-
tein receptor (Harvey et al., 2001), and van Kooyk and colleagues
demonstrated that gonococcal LOS inﬂuences dendritic cell func-
tion and subsequent immune responses that promote bacterial
survival (vanVliet et al., 2009).Mucosal anti-LOS antibodies could
interfere with these processes at very early stages of infection and
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potentially result in host immune responses that favor bacterial
clearance.
EXPRESSION AND ANTIGENIC VARIATION OF GONOCOCCAL
SURFACE STRUCTURES IN VIVO
The remarkable variation in surface structures expressed by dif-
ferent N. gonorrhoeae strains and the extraordinary plasticity of
the bacterial surface that an individual strain can present to its
infectedhost are hallmarks of the gonococcus that likely contribute
to high rates of recurrent gonococcal infection. The frequent
modulation of bacterial surface determinants results from a com-
bination of phase variation (the switch between on and off states
of gene expression) and antigenic variation (the expression of dif-
ferent antigenic versions of a structure) that result in differential
expression of outer membrane components including pili, Opa
proteins, and LOS (reviewed in Edwards and Apicella, 2004). The
genetic mechanisms that result in phase and antigenic variation
have been extensively characterized (reviewed in Simms and Jerse,
2005), and in vitro models of gonococcal interactions with host
cells indicate that different antigenic versions of pilin (the major
pilus subunit), Opa proteins, and LOS recognize different host cell
receptors, consistent with differential tissue tropism and patho-
genesis of naturally occurring gonococcal variants (Virji, 2009).
Phenotypic variation of these surface determinants occurs during
experimental infection in the male urethra.
LOS VARIATION AND MODIFICATION DURING EXPERIMENTAL
URETHRAL INFECTION
Production of multiple LOS structures occurs within a gonococcal
strain as well as within individual colonies of a given strain. Alter-
ations in LOS structures result from phase-variable production of
enzymes involved in extending carbohydrate structures from the
α- and β-chains of the core oligosaccharide. Variation in α-chain
residues is due to changes in polynucleotide repeat elements in
the lgtA, lgtC, and lgtD genes, encoding glycosyl transferases, orga-
nized in an operon that also includes lgtB and lgtE,whereasβ-chain
variation is due to alterations in a polynucleotide repeat in lgtG
(Banerjee et al., 1998). The different LOS structures resulting from
“phase-on”or“phase-off”expression of these genes, as well as vari-
able modiﬁcations of the oligosaccharide core (e.g., attachment of
phosphoethanolamine [PEA] to heptose I and II), can impact the
biologic properties of gonococci, altering bacterial susceptibility
to mediators of innate and acquired immune host defense and
attachment to host cells. A critical question is whether different
structures provide an advantage for gonococci during infection
and at different stages (e.g., before or after development of inﬂam-
mation). The importance of the lacto-N -neotetraose paraglobosyl
epitope of gonococcal LOS was recognized early in the history of
experimental infection with strain MS11mk. Following inocula-
tion of male volunteers with MS11mkA, which only produced a
3.6-kD lactosyl LOS and lacked higher molecular weight ganglio-
syl and paraglobosyl structures, gonococci isolated at the onset
of dysuria expressed gangliosyl LOS moieties, and bacteria iso-
lated at the onset of urethral discharge (including the MS11mkC
variant) expressed paraglobosyl structures (Schneider et al., 1991;
John et al., 1999). Gonococci isolated from symptomatic men
with naturally acquired gonorrhea also widely express ganglio-
syl or paraglobosyl LOS, but rarely express the lactosyl moiety
(Schneider et al., 1991). In the MS11 background, expression of
paraglobosyl LOS increased the apparent infectivity of the mkC
variant compared to themkAvariant (5/5 vs. 2/5 inoculated volun-
teers infected with 4× 104 cfu, Schneider et al., 1995), suggesting
that this structure is important in the pathogenesis of gonococcal
urethritis. However, N. gonorrhoeae strain FA1090, which is less
infectious than MS11mkC in the human model, also expresses a
paraglogosyl LOS. Thus, the relative infectivity of the two different
strains cannot be attributed to expression of this structure.
Taken together, the observations described above suggest that
gonococci producing gangliosyl or paraglobosyl LOS species are
at a selective advantage during infection of the male urethra. To
directly test this idea, Shafer and colleagues are constructing a vari-
ant of N. gonorrhoeae FA1090 that should not express gangliosyl or
paraglobosyl LOS due to an internal deletion that removes most of
lgtA and lgtC and all of lgtB. This mutant should only express the
3.6-kD lactosyl LOS structure. Competitive experimental infec-
tions with inocula containing this non-variable LOS mutant and
wild-type strain FA1090,which can freely phase vary its LOS struc-
tures, could determine whether phase-variable production of LOS
structures is important during infection. If the ability to alter LOS
structures during urethral infection is advantageous, the “locked-
in” mutant is predicted to have a ﬁtness defect or disadvantage
in vivo.
The lipid A core of gonococcal LOS has endotoxic activity, and
recent evidence indicates that PEA modiﬁcation at the 4′ position
is an important determinant in the capacity of strains to resist
complement-mediated killing by normal human serum (Lewis
et al., 2009; Balthazar et al., 2011). The presence of PEA can also
enhance resistance to cationic antimicrobial peptides. Interest-
ingly, PEA modiﬁcation at heptose II does not impart such resis-
tance. Shafer and co-workers have constructed an lptA deletion
mutant of N. gonorrhoeae strain FA1090 (W. M. Shafer, unpub-
lished data). Mixed experimental infections with this mutant,
which cannot modify lipid A with PEA, and wild-type FA1090 will
test whether PEA-containing lipid A provides a ﬁtness advantage
to gonococci during urethral infection.
The terminal paraglobosyl oligosaccharide recognized by Mab
3F11 and expressed by MS11mkC and FA1090 variants used in
experimental infection studies to date can be modiﬁed by gono-
coccal sialyltransferase, resulting in the addition of host-derived
sialic acid to the bacterial surface, mimicking human cell surface
antigens (Mandrell et al., 1988, 1990; Apicella et al., 1990; Par-
sons et al., 1994). Sialylation of gonococcal LOS in vitro increases
serum resistance of intrinsically serum sensitive strains (Grifﬁss
et al., 1991), promotes gonococcal resistance to killing by human
neutrophils (Kim et al., 1992; Rest and Frangipane, 1992; Wetzler
et al., 1992; Gill et al., 1996), and protects N. gonorrhoeae from the
bactericidal activity of porin and LOS-speciﬁc antibodies (Parsons
et al., 1989; Elkins et al., 1992;Wetzler et al., 1992; Gill et al., 1996).
Furthermore, immunoelectron microscopic analysis of gonococci
in urethral secretions frommenwith naturally acquired gonorrhea
indicates that sialylation occurs during infection (Apicella et al.,
1990). However, sialylation of MS11mkC prior to urethral inoc-
ulation appears to reduce infectivity of this strain and lengthen
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the incubation period for development of symptomatic urethritis
(Schneider et al., 1996). Sialylation also reduces gonococcal inva-
sion of primary urethral epithelial cells in vitro (Harvey et al.,
2001). These observations suggest that gonococcal sialylation in
the male urethra may occur after the initial stages of infection.
The presence or absence of sialylation of LOS may also be impor-
tant for bacterial survival during different phases of infection or
in different compartments during infection. For example, non-
sialylated gonococci may more easily enter urethral epithelial cells,
whereas sialylationmaybeprovideprotection from thebactericidal
effects of transudated serum that could affect extracellular bacteria
on the urethral mucosa. N. gonorrhoeae likely alternates between
intracellular and extracellular compartments during infection,and
variable LOS sialylation may facilitate transitions between these
compartments.
Sialyltransferase (lst ) mutants of N. gonorrhoeae MS11mkC
and FA1090 have been tested in the experimental human model,
and lst-deﬁcient gonococci from both backgrounds are able to
cause infection in the male urethra (J. G. Cannon, unpublished
data). After inoculation with an lst null mutant in the serum resis-
tant FA1090 background at an approximate ID80 for wild-type
FA1090, three out of four subjects became infected. FA1090lst
gonococci were recovered from the urine of all three infected sub-
jects; two developed urethral discharge during the 5-days after
inoculation, and the third remained asymptomatic during the
experimental trial. In the relatively serum sensitive MS11mkC
background at an approximate ID80 for the wild-type strain,
four out of eight subjects became infected after inoculation
with an lst null mutant. MS11mkClst gonococci were recov-
ered from the urine of all four infected subjects; two developed
urethral discharge during the 5-days after inoculation, and the
other two infected subjects remained asymptomatic during the
experimental trial.
Because asymptomatic experimental infection with wild-type
MS11mkC is rare, the lack of sialyltransferase activity may have
altered the pathogenesis of this strain in experimental urethral
infection. However, experimental human infection trials with
small numbers of subjects receiving individual inocula containing
only mutant or wild-type gonococci often does not provide suf-
ﬁcient power to demonstrate reduced infectivity or pathogenesis
with statistical conﬁdence. In experimental infection of female
mice inoculated with wild-type MS11 or an isogenic lst mutant,
Wu and Jerse saw no signiﬁcant difference in infectivity, consistent
with the results of experimental human infection. Using more
sensitive competitive infections in mice inoculated with mixtures
of wild-type gonococci and similar numbers of the lst mutant,
bacteria lacking lst were signiﬁcantly attenuated in the capacity
to colonize the lower female murine genital tract (Wu and Jerse,
2006). Competitive infections with mixed inocula in experimental
human infection may reveal an advantage for expression of sialyl-
transferase in MS11 and/or FA1090 in the male urethra that was
not apparent in previous infections with pure inocula.
The effects of differences in LOS expression on experimental
N. gonorrhoeae infection of male volunteers are summarized in
Table 2.
OPACITY (OPA) PROTEIN EXPRESSION DURING EXPERIMENTAL
URETHRAL INFECTION
Individual N. gonorrhoeae strains possess 11 or 12 opa genes, each
of which is subject to reversible, high frequency changes in expres-
sion state. As a result, individual gonococci can express one or
multiple different Opa proteins, or none at all. Sequence diversity
in regions of opa genes encoding antigenic determinants exposed
on the bacterial surface confers speciﬁcities for different receptors
on human cells. Most Opa variants bind to human carcinoembry-
onic antigen cell adhesion molecule (CEACAM) family receptors,
however a small number of Opa proteins bind heparin sulfate pro-
teoglycans (HSPGs). Opa-mediated interactions between gono-
cocci and host cells can activate neutrophils or suppress activation
and proliferation of CD4+ T lymphocytes, depending on which
receptors are engaged (reviewed in Sadarangani et al., 2011). Opa
protein repertoires of different N. gonorrhoeae strains differ in
primary amino acid sequences, and the nomenclature in the lit-
erature describing individual Opa proteins in different strains is
ambiguous. The opa genes of strains FA1090 and MS11 show little
homology in the variable regions encoding antigenic portions of
the proteins (Connell et al., 1990; Bhat et al., 1991), and proteins
referred to as OpaA,OpaB, etc., are not the same in the two strains.
Early observations by James and Swanson (1978) documented
that gonococci isolated from men with urethritis predominantly
formed the characteristically opaque colonies associated with Opa
protein expression. There is also strong selection for expression
of Opa proteins in the male urethra following inoculation with
wild-type variants of FA1090 orMS11mkC that are predominantly
Table 2 | Effects of lipoologosaccharide (LOS) features on experimental gonorrhea.
Phenotype tested Strain background Experimental outcome References
Natural phase variation
resulting in changes in LOS
structures
MS11mkC Expression of paraglobosyl structures
favored during infection
Schneider et al. (1995)
Ability to sialylate paraglobosyl
LOS structures
FA1090 (serum resistant) Sialyltransferase (lst ) mutant as
infectious as wild-type with pure inocula
J. G. Cannon (unpublished data)
MS11mkC (serum
sensitive)
Trend toward lower infectivity for lst
mutant compared to wild-type with pure
inocula
J. G. Cannon, (unpublished data)
LOS, lipooligosaccharide; lst, gene encoding gonococcal sialyltransferase.
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Opa-negative (Jerse et al., 1994; Schmidt et al., 2000). Schneider
and colleagues showed that transition from Opa-negative to Opa-
positive MS11mkC gonococci shed by experimentally infected
men is associated with the onset of symptoms (Schneider et al.,
1995, 1996; Schmidt et al., 2000). Using strain FA1090, Jerse et al.
(1994) showed that not only are Opa+ variants uniformly iso-
lated from urine and urethral swab cultures from experimentally
infected men, the proportion of isolates expressing multiple Opa
proteins increases over time. No single Opa protein in either
strain’s repertoire is selectively expressed during experimental
infection; different Opas predominated among colonies isolated
from individual subjects. However, there are Opa proteins in each
strain’s repertoire that appear to be under-represented among
isolates from experimentally infected subjects (Jerse et al., 1994;
Schmidt et al., 2000).
Following inoculation with predominantly Opa-negative
N. gonorrhoeae FA1090, variants expressing this strain’s OpaA
alone were not isolated from any of the subjects, and only a small
number of reisolates expressed OpaA in conjunction with one
or more other Opa proteins (Jerse et al., 1994). Opa-expressing
FA1090 have also been used to initiate experimental urethral
infections. Inoculation with 104 cfu of FA1090 expressing pre-
dominantly OpaA (along with the 3F11 LOS epitope and 98.8%
identical pilin amino acid sequence compared to the Opa-negative
inoculum variant) resulted in infection in four out of ﬁve sub-
jects, and three of the four infected subjects developed acute
urethritis within 1–3 days after inoculation. The fourth subject
shed gonococci in his urine, but remained asymptomatic during
the 4-day trial. Gonococci isolated at the onset of signs of acute
urethritis resulting from the predominantly OpaA inoculum con-
tinued to express OpaA, but in conjunction with one or more
other Opa proteins. Gonococci expressing multiple Opa proteins
represented a markedly higher proportion of isolates recovered
from subjects inoculated with FA1090 OpaA (mean 96.7%, range
92–100%; n = 3 subjects) than was observed with predominantly
Opa-negative inocula (mean 47.8%; range 18–100%; n = 9 sub-
jects) or with an FA1090 variant expressing predominantly OpaF
(mean 28.3%; range 7–75%; n = 3 subjects; J. G. Cannon andA. E.
Jerse, unpublished data). In contrast to FA1090 OpaA, the OpaF
protein was highly represented among reisolates from subjects
inoculated with Opa-negative FA1090 (Jerse et al., 1994). Thus,
gonococci expressing OpaA alone appeared to be at a disadvantage
during experimental urethral infection.
Rest and colleagues demonstrated that, in contrast to other
Opa variants of FA1090, OpaA variants are resistant to neutrophil
killing in vitro (Fischer and Rest, 1988; Elkins and Rest, 1990).
The relevance of in vitro Opa-mediated stimulation of neutrophils
to urethral pathogenesis is not clear. One might predict that
resistance to neutrophil killing would provide an advantage for
OpaA expression during infection. However, the rarity of OpaA
expression following inoculation with Opa-negative gonococci,
and the additional expression of other Opa proteins following
inoculation with OpaA expressers confound this hypothesis, as
presumably multiple expressers would be killed by neutrophils.
These results suggest that FA1090 OpaA may not mediate
key function(s) required for gonococcal survival in the male
urethra.
The rapid and uniform shift from Opa-negative to Opa pro-
tein expression by gonococci in the male urethra exhibited by both
wild-type strains FA1090 and MS11mkC suggested that the capac-
ity to express opacity proteins may be required during urethral
infection, and an Opa-deﬁcient FA1090 mutant was predicted to
be attenuated in the human experimental model. FA1090opaA-
K is a genetically deﬁned mutant in which all 11 opa genes of
this strain have been inactivated (Cole et al., 2010). Inoculation
with FA1090opaA-K at doses ranging from 5.5 to 6.4 Log10 cfu
resulted in infection in four out of eight subjects (J. G. Can-
non,unpublished data). FA1090opaA-K gonococci were recovered
from the urine of all four infected subjects; three of the four
developed urethral discharge within 4 days after inoculation, the
fourth remained asymptomatic during the 5-day experimental
trial. Thus, Opa protein expression is not required for gonococcal
infection in the male urethra.
Opa protein expression does confer an advantage in the late
stages of female murine genital tract using FA1090opaA-K and
a complemented strain that constitutively expresses OpaB, with
statistically signiﬁcant differences in colonization load observed
on days 9–14 of infection (Cole et al., 2010). Whether a sim-
ilar advantage for Opa expression could be demonstrated in
the human male urethra is not clear. Experimental infection in
men is limited to earlier stages of infection than can be studied
using the murine model; an advantage for Opa protein expres-
sion that did not manifest until later stages of urethral infection
could not be observed in the human model. The murine and
human genital tracts differ in expression of receptors for Opa pro-
teins, and the selective pressures inﬂuencing Opa protein expres-
sion in the male and female human genital tracts likely differ.
Thus, the apparent advantage conferred by Opa expression in the
female murine genital tract may not apply to urethral infection
in men.
PILIN EXPRESSION AND VARIATION IN VIVO
Gonococcal type 4 pili are important for attachment to host
cells, and phase and antigenic variation of PilE, the major pilin
protein, are thought to provide the gonococcus with mechanisms
of immune evasion and tissue tropism (reviewed in Virji, 2009).
Gonococci recovered from men and women with symptomatic,
naturally acquired gonorrhea are uniformly piliated (Kellogg et al.,
1963, 1968). Early experimental infections of male volunteers
(with N. gonorrhoeae strain F62) showed that piliated gonococci
were infectious and produced purulent urethral exudates, and
virulence was retained after extensive selective passage in vitro
(Kellogg et al., 1963). In contrast, though non-piliated inocula
were infectious, infected men developed a watery urethral dis-
charge or none at all (Kellogg et al., 1968). Furthermore, after
extensive passage in vitro, non-piliated F62 gonococci were non-
infectious (Kellogg et al., 1963). Regardless of whether piliated
or non-piliated inocula were used, gonococci recovered from
infected subjects were uniformly piliated (Kellogg et al., 1963,
1968).
Rapid and extensive antigenic variation of PilE has been shown
to occur during experimental urethral infection with N. gonor-
rhoeae FA1090 (Seifert et al., 1994; Wright et al., 1994; Ham-
rick et al., 2001) and MS11mk (Swanson et al., 1987). These
Frontiers in Microbiology | Cellular and Infection Microbiology May 2011 | Volume 2 | Article 123 | 6
Hobbs et al. Experimental human gonorrhea
observations suggested that type 4 pilus expression may be
required for urethral gonococcal infection, and a non-reverting,
non-piliated FA1090 mutant was predicted to be non-infectious
in the human experimentalmodel. The promoter and 5′ end of the
single pilin expression locus was deleted in FA1090pilE (Cannon
et al., 1996). Inoculation with approximately 106 cfu (∼ID80 for
piliated wild-type FA1090) of Opa-negative FA1090pilE express-
ing the paraglobosyl LOS epitope recognized byMab 3F11 resulted
in infection in six out of eight subjects (J. G. Cannon, unpub-
lished data). Non-piliated gonococci were cultured from urine
from all infected subjects. Three of the six subjects infected with
the pilE mutant developed a watery urethral discharge, and the
remaining subjects remained asymptomatic throughout the 5-day
experimental trial, consistent with Kellogg et al. (1963, 1968) ear-
lier observations with phase-variable, non-piliated inocula that
switched to pilus expression during infection. These results sug-
gest that host responses to piliated and non-piliated gonococci
may differ during early stages of urethral infection. The fact
that pilus expression is not required for infection in men sug-
gests there may be a role for alternative adhesins in urethral
colonization.
Although FA1090pilE does not elaborate a pilus ﬁber, this
mutant does express the pilus-associated PilC protein, which can
be present both in pilus ﬁbers and in the gonococcal outer mem-
brane (Rudel et al., 1995; Rahman et al., 1997). PilC is important
for adherence of piliated gonococci to human epithelial cells
(Rudel et al., 1992; Nassif et al., 1994; Kirchner and Meyer, 2005),
and in the absence of PilE, PilC has also been shown to increase
adherence of FA1090 to epithelial cells in vitro, though the effect of
PilC expression on non-piliated gonococci is modest compared to
adherence of piliated bacteria (C. E. Thomas, unpublished data).
Mixed experimental infections with FA1090pilE expressing PilC
and a mutant that expresses neither PilE nor PilC may help eluci-
date the roles of these two proteins in gonococcal pathogenesis in
the male urethra.
The effects of opacity protein and pilin expression on experi-
mental N. gonorrhoeae infection of male volunteers are summa-
rized in Table 3.
IgA PROTEASE IS NOT REQUIRED DURING EXPERIMENTAL
GONOCOCCAL URETHRITIS
IgA1 protease production is associated with mucosal pathogens
including N. gonorrhoeae, N. meningitidis, and Haemophilus
inﬂuenzae (Kilian et al., 1996). In addition to its ability to cleave
IgA1 at mucosal surfaces, gonococcal IgA1 protease also cleaves
the lysosome-associated membrane protein 1 (Lamp1) promot-
ing intracellular bacterial survival in epithelial cells in vitro (Lin
et al., 1997; Ayala et al., 2002). These observations suggested that
the enzyme may contribute to gonococcal pathogenesis. Cannon
and colleagues showed that a N. gonorrhoeae FA1090 iga mutant
(Opa−, P+, and expressing the 3F11 LOS epitope) that lacks
IgA1 protease activity is fully capable of causing urethritis in male
volunteers (Johannsen et al., 1999).
IgA1 protease could be more important in later stages of infec-
tion than can be assessed in the human model of uncomplicated
urethritis in naïve volunteers. Protease function could contribute
to later-stage invasive complications, or may play a role in reinfec-
tion of previously exposed individuals by inactivating pre-existing
mucosal antibodies (Johannsen et al., 1999). The role of IgA1
protease in gonococcal infection in women has not been tested.
IMPORTANCE OF TRANSFERRIN AND LACTOFERRIN
RECEPTORS IN GONOCOCCAL PATHOGENESIS
Like all N. gonorrhoeae strains, FA1090, and MS11mkC can use
iron from human transferrin (Tf) for growth. One of the notable
differences between these two strains (Table 1) is their differen-
tial ability to obtain iron from human lactoferrin (Lf). MS11mkC
expresses lactoferrin-binding protein A (LbpA) and is phenotypi-
cally Tf+Lf+, whereas FA1090 has a naturally occurring deletion
that eliminates expression of LbpA and is unable to grow on
lactoferrin as a sole source of iron (Anderson et al., 2003). Thus,
wild-type FA1090, like approximately half of clinical isolates of N.
gonorrhoeae that have been examined (Mickelsen et al., 1982; Fox
et al., 1998;Anderson et al., 2001), is phenotypically Tf+Lf−. Cor-
nelissen et al. (1998) showed that a transferrin-receptor mutant of
FA1090,which cannot obtain iron from either Tf or Lf, is incapable
of causing urethritis in the experimental human gonorrheamodel.
Table 3 | Effects of opacity protein (Opa) and pilin (PilE) expression on experimental gonorrhea.
Phenotype tested Strain background Experimental outcome References
Natural phase variation
resulting in changes in Opa
expression
MS11mkC and FA1090 Opa expression favored during infection
after inoculation with Opa-negative
variant
Jerse et al. (1994), Schmidt et al.
(2000)
Requirement for Opa
expression
FA1090 Mutant unable to express Opa proteins
as infectious as wild-type
J. G. Cannon (unpublished data)
Natural antigenic variation in
PilE protein
MS11mkC and FA1090 Extensive variation observed during
infection with piliated variant
Seifert et al. (1994),Wright et al.
(1994), Hamrick et al. (2001),
Swanson et al. (1987)
Requirement for PilE
expression
FA1090 Non-piliated mutant unable to express
PilE as infectious as wild-type
J. G. Cannon (unpublished data)
Opa, opacity protein; PilE, pilin protein.
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Sparling and colleagues showed that a N. gonorrhoeae FA1090
engineered mutant capable of using Lf but not Tf, a combina-
tion not seen in nature, causes experimental urethral infection in
male volunteers that is similar to infections caused by wild-type
FA1090 (Anderson et al., 2003). Thus iron from either Tf or Lf
enables gonococcal growth and pathogenesis in the male urethra.
To determine whether the ability to use human Lf provides
an advantage to gonococci that also can use human Tf, Sparling
and colleagues conducted competitive infections with wild-type
FA1090 (Tf+Lf−) and a Tf+Lf+ mutant. Inoculation with an
approximate ID50 for wild-type FA1090 containing a mixture of
equivalent numbers of both strains resulted in infection in nearly
half of subjects. In each of ﬁve infected subjects, the Tf+Lf+
strain exhibited a signiﬁcant competitive advantage over wild-
type FA1090; urine and urethral swab cultures from all subjects
contained 100% mutant gonococci at the end of the experimen-
tal trial (Anderson et al., 2003). Thus, the experimental model
using a competitive infection study design has the potential to
demonstrate differences in ﬁtness between gonococcal strains with
statistical conﬁdence, even when the overall infectivity of the two
strains is not demonstrably different.
The requirements for IgA protease and iron acquisition from
human iron-binding proteins during experimentalN. gonorrhoeae
infection of male volunteers are summarized in Table 4.
POPULATION DYNAMICS IN EXPERIMENTAL INFECTION
Tracking the variation of opacity and pilin proteins during experi-
mental infection with wild-type N. gonorrhoeae reveals that the
phenotype of infecting bacteria changes multiple times in the
interval between inoculation and the development of urethral dis-
charge (Jerse et al., 1994; Seifert et al., 1994; Wright et al., 1994;
Schmidt et al., 2000; Hamrick et al., 2001). As shown schemat-
ically in Figure 2, inoculum variants disappear rapidly and are
replaced by a series of new variants expressing different combi-
nations of surface antigens. The gonococcal population becomes
more complex as infection proceeds, consisting of a mixture of
multiple variants at the time a urethral discharge is present. These
changes are consistent with sequential outgrowth and disappear-
ance of clonal populations expressing combinations of Opa and
FIGURE 2 | Population dynamics during experimental gonococcal
infections.The schematic representation depicts an inoculating population
that is predominantly composed of one combination of variable traits,
represented by red in the ﬁrst pie chart and the red trace in the graph
below. Following the eclipse period during which few gonococci are
recovered, new variants, indicated by different colors, emerge. The
population of infecting gonococci becomes increasingly complex over time.
The colors represent different phenotypic variants that could arise by phase
and/or antigenic variation of opacity and pilin proteins and are based on
previously reported observations (Jerse et al., 1994; Seifert et al., 1994;
Wright et al., 1994; Hamrick et al., 2001) but are not intended to represent
speciﬁc characteristics of actual reisolates from an experimental infection.
PilE andpossibly other traits. The eclipse period that occurs imme-
diately after inoculation could result in a population bottleneck,
with the subsequent gonococcal population expanding from one
or a few organisms present in the inoculum. New variants gen-
erated through phase and antigenic variation may descend from
a single organism; these new variants proliferate if they express
advantageous combinations of traits and eventually replace the
previous population.
The selective pressures that could result in the sequential out-
growth and disappearance of gonococcal variants are not known.
However, the possibility that very few bacteria emerge from a
Table 4 | Requirements for IgA protease and iron acquisition from human iron-binding proteins during experimental gonorrhea.
Phenotype tested Strain background Experimental outcome References
Requirement for IgA protease activity FA1090 Mutant unable to express IgA protease
as infectious as wild-type
Johannsen et al. (1999)
Requirement for lactoferrin (Lf)
utilization in the absence of transferrin
(Tf) utilization
FA1090 Mutant unable to use either Lf or Tf is
non-infectious
Cornelissen et al. (1998)
Ability to use Lf in the absence of Tf
utilization
FA1090 Mutant able to use Lf only as infectious
as wild-type that usesTf only
Anderson et al. (2003)
Ability to use both Lf andTf FA1090 Mutant able to use both Lf andTf
showed competitive advantage over
wild-type in mixed infections
Anderson et al. (2003)
IgA, immunoglobulin A; Lf, lactoferrin; Tf, transferrin.
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selective bottleneck to initiate infection following the initial eclipse
period could confound interpretation of results frommixed exper-
imental infections with isogenic strains differing in expression of a
postulated virulence factor. Figure 3A shows theoretical outcomes
of mixed infection initiated under conditions with and without
the hypothetical bottleneck. In the absence of a dramatic popula-
tion restriction, gonococcal populations reisolated from infected
subjects would be expected to contain mixtures of the two strains
in similar proportions to their representation in the inoculum, if
they have equal ﬁtness during infection (Pattern A). If one strain
has a competitive advantage, this strain would eventually predom-
inate among reisolated bacteria (Pattern B). If the bottleneck does
reduce the infecting gonococcal population to very few bacteria,
and one strain has a competitive advantage, that strain would be
expected to predominate early among reisolates and be recovered
exclusively from all infected subjects (Pattern C). If both input
strains have equivalent ﬁtness, each would be equally likely to sur-
vive the bottleneck,and each shouldpredominate among reisolates
from roughly half of infected subjects (Pattern D).
Figure 3B shows the actual results of mixed infections with
wild-type Tf+Lf− and mutant Tf+Lf+ N. gonorrhoeae FA1090
strains. Perhaps not surprisingly, the data do not ﬁt clearly into one
single predicted outcome pattern. From over half of the infected
subjects (3/5), only Tf+Lf+ gonococci were recovered following
a noticeable eclipse. From the other two subjects, Tf+Lf+ gono-
cocci eventually overtook the population after mixtures of both
inoculating strains were recovered. The persistence of substantial
numbers of both input strainswith gradual out competition by the
Tf+Lf+ strain in some subjects suggests that there is not a univer-
sal bottleneck limiting the establishment of experimental urethral
infection tooneor a fewgonococci in the infectingpopulation.The
fact that cultures from all infected subjects ultimately contained
100% Tf+Lf+ gonococci suggests that this strain had a selective
advantage over the Tf+Lf− wild-type strain during experimental
infection of the male urethra. However, the population dynamics
appeared to be different in different subjects. It is possible that
there are individual differences in the effectiveness of innate host
defenses, and these could affect the number of organisms in
the original inoculum that survive and replicate to generate the
infecting population.
Interpretation of mixed experimental infections could be fur-
ther confounded by the potential for in vivo transformation
between co-infecting gonococcal cells. In vitro models suggest that
transformation during infection is possible, and the formation of
mosaic genes is indirect evidence that it occurs in the human host.
Gonococcal isolates that have been recovered to date from subjects
inoculatedwithmixtures of isogenic strains showedno evidence of
transformation during the relatively short experimental infection
period (Anderson et al., 2003). However, only genetic exchanges
that resulted in mosaic structures involving the engineered gene
would have been detected. Recent improvements in whole genome
sequencing technologies may enable a more comprehensive and
sensitive approach to explore whether horizontal genetic exchange
occurs during experimental urethral infection.
SAFETY AND UTILITY OF THE EXPERIMENTAL HUMAN
GONORRHEA MODEL
Experimental infection of male volunteers with N. gonorrhoeae is
safe, and subjects infected with wild-type gonococci exhibit the
signs and symptoms of natural infection. The risks of serious
complications from urethral gonococcal infection are extremely
rare, even in natural infection. Hundreds of subjects have par-
ticipated in experimental infection trials without severe adverse
events. Using a competitive infection design with mixed inocula,
the model can discriminate among gonococcal strains with dif-
ferent degrees of ﬁtness for urethral colonization and infection.
Experience with the FA1090 transferrin-receptor mutant showed
that it is possible to render N. gonorrhoeae non-infectious by inac-
tivation of a single virulence factor (in a strain that does not
express the lactoferrin receptor). Thus theurethral infectionmodel
FIGURE 3 | Potential influence of population dynamics on outcomes
of mixed experimental infections. In (A), theoretical outcomes are
shown for infections initiated by a 50:50 mixture of two isogenic strains
differing in expression of a predicted virulence factor, depicted
as black and white, under conditions with (bottom) and without (top) a
population-restricting bottleneck early after inoculation. Potential
outcomes consistent with and without a competitive advantage for the
black strain are indicated as four patterns of pie charts representing
populations of gonococci recovered from infected subjects. In (B), actual
outcomes are shown for infections initiated by a 45:55 mixture of isogenic
Tf+Lf− (white) andTf+Lf+ (black) strains of N. gonorrhoeae FA1090
(Anderson et al., 2003). In patterns 1–3, each pie chart represents the mixture
of gonococcal strains recovered from infected subjects over the 1- to 5-day
period after inoculation. The  symbol indicates no gonococci were recovered
at early times (1–3 days in different volunteers) after inoculation of four
subjects.
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is well-suited to provide insights into the mechanisms of patho-
genesis of N. gonorrhoeae and eventually may prove useful as a
component in the clinical development plan for the evaluation of
a gonococcal vaccine.
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